| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.046 | 0.8 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.057 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |